Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein ...

In ancient Greek lore, Proteus, son of Poseidon, held the allure of wisdom and foresight, yet could only be approached by those with the means to capture him. Much like this mythical figure, proteins, ...

Life runs on instructions you never see. Every cell reads DNA, turns that message into RNA, and then builds proteins that ...

Barcoding technologies that take advantage of the high information content that can be encoded in oligonucleotide sequences have enabled a wide array of applications in biotechnology, particularly ...

Proteins, through their diversity, are vital determinants of phenotype and function. Humans possess potentially millions of protein variants (proteoforms), derived through mechanisms including ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Liberate Bio, a Boston-based ...

Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...

San Diego’s Illumina is the world leader in gene sequencing technology — the ability to read and record DNA. Now, the billion ...